Cerity Partners’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Buy
27,645
+4,817
+21% +$311K ﹤0.01% 1559
2025
Q4
$1.4M Buy
22,828
+2,959
+15% +$169K ﹤0.01% 1535
2025
Q3
$1.04M Buy
19,869
+266
+1% +$13.4K ﹤0.01% 1586
2025
Q2
$883K Buy
+19,603
New +$809K ﹤0.01% 1578
2025
Q1
Sell
-11,043
Closed -$514K 2553
2024
Q4
$514K Buy
11,043
+136
+1% +$6.97K ﹤0.01% 1744
2024
Q3
$573K Buy
+10,907
New +$541K ﹤0.01% 1701

Other funds holding LIVN

Cerity Partners's LIVN Position: Q1 2026 in Review

Cerity Partners increased its LivaNova (LIVN) stake by 21% in Q1 2026, buying an estimated $311K and bringing the position to 27,645 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Cerity Partners first reported a position in LIVN in Q3 2024 and has held it in 6 quarters since. 290 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.

  • Cerity Partners held 27,645 shares of LivaNova worth $1.76M as of Q1 2026.
  • Cerity Partners bought 4,817 LivaNova shares in Q1 2026, an estimated $311K.
  • LivaNova made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1559 holding.
  • Cerity Partners first reported a position in LivaNova in Q3 2024 and has held it in 6 quarters since.
  • 290 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.